Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line

Archivum Immunologiae et Therapiae Experimentalis

Volumn 61, Issue 1, 2013, Pages 75-83

  Shoae Hassani, Alireza ^a   Mortazavi Tabatabaei, Seyed Abdolreza ^a,b   Sharif, Shiva ^a,c   Madadi, Shabnam ^c   Rezaei Khaligh, Hamidreza ^a   Verdi, Javad ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nanobioparticle; Nanobody; Nanomedicine; Recombinant

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; NANOBODY;

ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BACTERIOPHAGE LAMBDA; BINDING AFFINITY; BREAST CARCINOMA; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; PHAGE DISPLAY; PROTEIN EXPRESSION; PROTEIN TARGETING; VHG GENE;

ADULT STEM CELLS; ANIMALS; ANTIBODY AFFINITY; BACTERIOPHAGE LAMBDA; BREAST NEOPLASMS; CAMELIDS, NEW WORLD; CARCINOMA; CELL PROLIFERATION; CELL SURFACE DISPLAY TECHNIQUES; CYTOMEGALOVIRUS; EPITOPES, B-LYMPHOCYTE; GENES, MYC; GENETIC ENGINEERING; HUMANS; MCF-7 CELLS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ERBB-2; SINGLE-DOMAIN ANTIBODIES;

EID: 84872601326     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0206-x     Document Type: Article

References (39)

1. Ahmadvand D, Rasaee MJ, Rahbarizadeh F et al (2009) Cell selection and characterization of a novel human endothelial cell specific nanobody. Mol Immunol 46:1814-1823
2. Arbabi Ghahroudi M, Desmyter A et al (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414:521-526
3. Barbas CF, Burton DR, Scott JK et al (2001) Phage display: a laboratory manual. Cold Spring Harbor Press, New York
4. Burvenich I, Schoonooghe S, Cornelissen B et al (2005) In vitro and in vivo targeting properties of iodine-123 or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model. Clin Cancer Res 11:7288-7296
5. Catherine D, Jepson CD, Clark J et al (2004) Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 22:2413-2419
6. Conrath KE, Lauwereys M, Wyns L et al (2001) Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J Biol Chem 276:7346-7350
7. Conrath KE, Pereira AS, Martins CE et al (2009) Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase. Protein Sci 18:619-628
8. Cortez-Retamozo V, Lauwereys M, Hassanzadeh GhG et al (2002) Efficient tumor targeting by single-domain antibody fragments of camels. Int J Cancer 98:456-462
9. De Genst E, Areskoug D, Decanniere K et al (2002) Kinetic and affinity predictions of a protein-protein interaction using multivariate experimental design. J Biol Chem 277:29897-29907
10. De Genst E, Silence K, Decanniere K et al (2006) Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci USA 103:4586-4591
11. Dokland T, Murialdo H (1993) Structural transitions during maturation of bacteriophage lambda capsids. J Mol Biol 233:682-694
12. Dumoulin M, Conrath K, Van Meirhaeghe A et al (2002) Single-domain antibody fragments with high conformational stability. Protein Sci 11:500-515
13. Gainkam LO, Huang L, Caveliers V et al (2008) Comparison of the bio distribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. J Nucl Med 49:788-795
14. Goldenberg DM, Sharkey RM (2007) Novel radiolabeled antibody conjugates. Oncogene 26:3734-3744
15. Hajitou A, Pasqualini R, Arap W (2006a) Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc Med 16:80-88
16. Hajitou A, Trepel M, Lilley CE et al (2006b) A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 125:385-398
17. Henderson KA, Streltsov VA, Coley AM et al (2007) Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure 15:1452-1466
18. Hmila I, Ben Abdallah BA, Saerens D et al (2008) VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI. Mol Immunol 45:3847-3856
19. Hofman EG, Ruonala MO, Bader AN et al (2008) EGF induces coalescence of different lipid rafts. J Cell Sci 121:2519-2528
20. Ivanenkov VV, Menon AG (2000) Peptide-mediated transcytosis of phage display vectors in MDCK cells. Biochem Biophys Res Commun 276:251-257
21. Jaramillo ML, Leon Z, Grothe S, Paul-Roc B et al (2006) Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting. Exp Cell Res 312:2778-2790
22. Kontermann R, Dubel S (2001) Antibody Engineering. Springer, Berlin
23. Lankes H, Zanghi CN, Santos K et al (2007) In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol 102:1337-1349
24. Larocca D, Jensen-Pergakes K, Burg MA et al (2001) Receptor targeted gene delivery using multivalent phagemid particles. Mol Ther 3:476-484
25. March J, Clark J (2004) Genetic immunization against hepatitis B using whole bacteriophage lambda particles. Vaccine 22:1666-1671
26. Murialdo H, Ray PN (1975) Model for arrangement of minor structural proteins in head of bacteriophage lambda. Nature 257:815-817
27. Nguyen VK, Desmyter A, Muyldermans S (2001) Functional heavy chain antibodies in Camelidae. Adv Immunol 79:261-296
28. Perez-Torres M, Guix M, Gonzalez A et al (2006) Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations. J Biol Chem 281:40183-40192
29. Presta L (2006) Engineering of therapeutic antibodies to minimize immunogenicity and optimize function. Adv Drug Deliv Rev 58:640-656
30. Rahbarizadeh F, Rasaee MJ, Forouzandeh M et al (2006) Over expression of anti-MUC1 single domain antibody fragments in the yeast Pichia pastoris. Mol Immunol 43:426-435
31. Saerens D, Kinne J, Bosmans E et al (2004) Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen. J Biol Chem 279:51965-51972
32. Saerens D, Frederix F, Reekmans G et al (2005) Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing. Anal Chem 77:7547-7555
33. Sambrook J, Russel D (2001) Mulecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor, NewYork
34. Shoae-Hassani A, Amirmozafari N, Ghaemi A (2009) Virulence increasing of Salmonella typhimurium in Balb/c mice after heat-stress induction of phage shock protein A. Curr Microbiol 59:446-450
35. Sidhu SS, Lowman HB, Cunningham BC et al (2000) Phage display for selection of novel binding peptides. Methods Enzymol 328:333-363
36. Spinelli S, Frenken IGF, Hermans P et al (2000) Camelid heavy-chain variable domains provide efficient combining sites to haptens. Biochemistry 39:1217-1222
37. Tereshko V, Uysal S, Koide A et al (2008) Toward chaperone-assisted crystallography, protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold. Protein Sci 17:1175-1187
38. Van Der Linden R, Frenken L, De Geus B et al (1999) Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochem Biophys Acta 1431:37-46
39. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137